Report for: Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease

Title	Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease
Published in	Cochrane database of systematic reviews, July 2006
DOI	10.1002/14651858.cd001104.pub2
Pubmed ID	16855959
Authors	Sarah Appleton, Phillippa Poole, Brian J Smith, Antony Veale, Toby J Lasserson, Matthew Ming Ki Chan, Christopher J Cates

View on publisher site Alert me about new mentions

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United Kingdom	2	1%
United States	1	<1%
Unknown	146	98%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	29	19%
Researcher	18	12%
Student > Bachelor	16	11%
Student > Ph. D. Student	14	9%
Student > Doctoral Student	9	6%
Other	22	15%
Unknown	41	28%

Readers by discipline	Count	As %
Medicine and Dentistry	63	42%
Nursing and Health Professions	13	9%
Social Sciences	6	4%
Psychology	5	3%
Agricultural and Biological Sciences	3	2%
Other	16	11%
Unknown	43	29%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2018.

All research outputs

#4,165,464

of 22,758,963 outputs

Outputs from Cochrane database of systematic reviews

#6,621

of 12,314 outputs

Outputs of similar age

#10,555

of 65,522 outputs

Outputs of similar age from Cochrane database of systematic reviews

#29

of 70 outputs

Altmetric has tracked 22,758,963 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 65,522 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.

We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.

Cochrane Database of Systematic Reviews

Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease

About this Attention Score

Mentioned by

Citations

Readers on

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context